Anticoagulant and Antiplatelet Prescribing Patterns for Patients with Atrial Fibrillation after Percutaneous Coronary Intervention

BACKGROUND: Current guidelines recommend triple antithrombotic therapy (TAT), defined as acetylsalicylic acid (ASA), clopidogrel, and warfarin, for patients with nonvalvular atrial fibrillation who have undergone percutaneous coronary intervention with stent implantation. The choice of anticoagulant...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Can J Hosp Pharm
Egile Nagusiak: Woods, Erin A, Ackman, Margaret L, Graham, Michelle M, Koshman, Sheri L, Boswell, Rosaleen M, Barry, Arden R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Canadian Society of Hospital Pharmacists 2016
Gaiak:
Original Research / Recherche Originale
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008423/
https://ncbi.nlm.nih.gov/pubmed/27621487
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak